A genetics‑guided small molecule called compound 6 gently turns down an overactive immune pathway (CARD9), offering a more precise, durable, and potentially safer treatment strategy for Crohn’s ...
This marks the first live procedure at AAHS, as well as a first for Keenova. Treatment takes place over two days of annual meeting—injection on Wednesday and finger extension on Friday. Audience of ...
DUBLIN, Jan. 13, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that a new presentation related to Dupuytren's contracture (DC) and XIAFLEX® (collagenase clostridium histolyticum, or ...
Analysis to Be Presented at the American Association for Hand Surgery Meeting DUBLIN, Jan. 13, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that a new presentation related to ...
"These survey results highlight the need to raise awareness of Dupuytren's contracture and to empower patients to seek care earlier through patient–provider conversations," said Dr. Philip Blazar, ...
Conducted in March 2024, the online survey explored perceptions of DC, treatment attributes, and satisfaction across three treatment options: surgery, collagenase clostridium histolyticum (CCH) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results